Pathologic Correlates of Nondemented Aging, Mild Cognitive Impairment, and Early-Stage Alzheimer's Disease

Cited by (511)

Items 301–400 of 511

1. Regional Cortical Thickness Predicts Top Cognitive Performance in the Elderly
   Elena Nicole Dominguez, Shauna M. Stark, Yueqi Ren, María M. Corrada, Claudia H. Kawas, Craig E.L. Stark · 2021 · Frontiers in Aging Neuroscience
2. Racial differences in longitudinal Alzheimer's disease biomarkers among cognitively normal adults
   Chengjie Xiong, Jingqin Rosy Luo, Suzanne E. Schindler, Anne M. Fagan, Tammie L.S. Benzinger, Jason J. Hassenstab, Joyce E. Balls‐Berry, Folasade Agboola, Elizabeth Grant, Krista L. Moulder et al. · 2022 · Alzheimer s & Dementia
3. Tau PET Imaging for Staging of Alzheimer's Disease in Down Syndrome
   Michael S. Rafii · 2018 · Developmental Neurobiology
4. A computational method for computing an Alzheimer's disease progression score; experiments and validation with the ADNI data set
   Bruno Jedynak, Bo Liu, Andrew Lang, Yulia R. Gel, Jerry L. Prince · 2014 · Neurobiology of Aging
5. Dysexecutive syndrome and cerebrovascular disease in non-amnestic mild cognitive impairment: a systematic review of the literature
   Felipe Kenji Sudo, Carlos Eduardo de Oliveira Alves, Gilberto Sousa Alves, Letice Ericeira-Valente, Chan Tiel, Denise Madeira Moreira, Jerson Laks, Eliasz Engelhardt · 2012 · Dementia & Neuropsychologia
6. Homing in on Intracellular Aβ?
   Todd Eliot Golde, Christopher Janus · 2005 · Neuron
7. Quantitative in vivo biomarkers of oxidative damage and their application to the diagnosis and management of Alzheimer's disease
   Thomas Jude Montine, Joseph F. Quinn, Kathleen S. Montine, Jeffrey Alan Kaye, John C.S. Breitner · 2006 · Journal of Alzheimer s Disease
8. High throughput object-based image analysis of β-amyloid plaques in human and transgenic mouse brain
   Harry Samaroo, Alan Opsahl, Jan Schreiber, Sharon O'Neill, Michael Marconi, Jessie Qian, Santos Carvajal‐Gonzalez, Barbara A. Tate, Anthony J. Milici, Kelly R. Bales et al. · 2011 · Journal of Neuroscience Methods
9. Characteristics of the cognitive function transition and influencing factors among Chinese older people: An 8-year longitudinal study
   Yurun Du, Naifan Hu, Zhenfan Yu, Xiaojuan Liu, Yuzhuo Ma, Jiangping Li · 2022 · Journal of Affective Disorders
10. Neuropathology‐based APOE genetic risk score better quantifies Alzheimer's risk
    Yuetiva K. Deming, Eva Vasiljevic, Autumn Rose Morrow, Jiacheng Miao, Carol Van Hulle, Erin McMullen Jonaitis, Yue Ma, Vanessa M Whitenack, Gwendlyn Kollmorgen, Norbert Wild et al. · 2023 · Alzheimer s & Dementia
11. Molecular imaging as a guide for the treatment of central nervous system disorders
    Euitae Kim, O. Howes, S. Kapur · 2013 · Dialogues in Clinical Neuroscience
12. Microstructural and Cerebral Blood Flow Abnormalities in Subjective Cognitive Decline Plus: Diffusional Kurtosis Imaging and Three-Dimensional Arterial Spin Labeling Study
    Zhongxian Yang, Rong Yu, Zhen Cao, Yi Wu, Xinzhu Zhao, Qiuxia Xie, Min Luo, Yubao Liu · 2021 · Frontiers in Aging Neuroscience
13. Towards a cognitive stimulation program using an errorless learning paradigm in amnestic mild cognitive impairment
    Martine Simard · 2008 · Neuropsychiatric Disease and Treatment
14. Amyloid, memory and neurogenesis
    David Morgan · 2007 · Experimental Neurology
15. Generation of Clickable Pittsburgh Compound B for the Detection and Capture of β-Amyloid in Alzheimer’s Disease Brain
    Ian Diner, Jeromy M. Dooyema, Marla Gearing, Lary C. Walker, Nicholas T. Seyfried · 2017 · Bioconjugate Chemistry
16. Are We Ready? The Construct of Subjective Cognitive Impairment and its Utilization in Clinical Practice: A Preliminary UK-Based Service Evaluation
    Amy E. Jenkins, Andrea Tales, Jeremy John Tree, Antony J. Bayer · 2015 · Journal of Alzheimer s Disease
17. Integration of probabilistic regulatory networks into constraint-based models of metabolism with applications to Alzheimer’s disease
    Han Yu, Rachael Hageman Blair · 2019 · BMC Bioinformatics
18. Preventing Vascular Effects on Brain Injury and Cognition Late in Life: Knowns and Unknowns
    Owen Thomas Carmichael · 2014 · Neuropsychology Review
19. Genetic and Molecular Evaluation of SQSTM1/p62 on the Neuropathologies of Alzheimer’s Disease
    Wei Dong, Mengchao Cui, Wenzheng Hu, Qi Zeng, Yilong Wang, Wei Zhang, Yue Ming Huang · 2022 · Frontiers in Aging Neuroscience
20. Association of balance control mechanisms with brain structural integrity in older adults with mild cognitive impairment
    Lakshmi Kannan, Tanvi S. Bhatt, Aifeng Zhang, Olusola Ajilore · 2022 · Neuroscience Letters
21. Alterations in hippocampus-centered morphological features and function of the progression from normal cognition to mild cognitive impairment
    Xiuxiu Wang, Lixin Peng, Shiqi Zhan, Xiaolong Yin, Li Ting Huang, Jiayan Huang, Junchao Yang, Yusi Zhang, Yi Zeng, Shengxiang Liang · 2024 · Asian Journal of Psychiatry
22. Characterization of Japanese-American men with a single neocortical AD lesion type
    Helen Petrovitch, George Webster Ross, Qimei He, Jane H. Uyehara‐Lock, William R. Markesbery, Daron G. Davis, James R. Nelson, Kamal Masaki, Lenore J. Launer, Lon R. White · 2007 · Neurobiology of Aging
23. Chitinase-3-like 1 protein (CHI3L1) locus influences cerebrospinal fluid levels of YKL-40
    Yuetiva K. Deming, Kathleen Black, David Carrell, Yefei Cai, Jorge L. Del‐Aguila, María Victoria Fernández, John Budde, ShengMei Ma, Benjamin A. Saef, Bill Howells et al. · 2016 · BMC Neurology
24. Assessing Neuroprotective Agents for Aβ-Induced Neurotoxicity
    Kelly H. Forest, Robert A. Nichols · 2019 · Trends in Molecular Medicine
25. A Therapeutic Approach for Senile Dementias: Neuroangiogenesis
    Charles T. Ambrose · 2014 · Journal of Alzheimer s Disease
26. Characterization of potential plasma biomarkers related to cognitive impairment by untargeted profiling of phospholipids using the HILIC-ESI-IT-TOF-MS system
    Shuang Song, Ling‐Zhi Cheong, Qingqing Man, Shaojie Pang, Yue-Qi Li, Biao Ren, Jian Zhang · 2018 · Analytical and Bioanalytical Chemistry
27. Treatment of the mild cognitive impairment (MCI)
    H. Allain, Danièle Bentué‐Ferrer, Yvette Akwa · 2007 · Human Psychopharmacology Clinical and Experimental
28. Biomarkers for Alzheimer’s disease
    Joshua Aaron Sonnen, Christopher Dirk Keene, Kathleen S. Montine, Ge Li, Elaine R. Peskind, Jing Zhang, Thomas Jude Montine · 2007 · Expert Review of Neurotherapeutics
29. BDNF and COMT polymorphisms have a limited association with episodic memory performance or engagement in complex cognitive activity in healthy older adults
    Kimberley E. Stuart, Mathew James Summers, Michael Valenzuela, James Clement Vickers · 2014 · Neurobiology of Learning and Memory
30. Cholinesterase inhibitors affect brain potentials in amnestic mild cognitive impairment
    Rie Irimajiri, Henry J. Michalewski, Edward J. Golob, Arnold Starr · 2007 · Brain Research
31. CSF phospho-tau is independent of age, cognitive status and gender of neurological patients
    Armin Scheurich, Peter Paul Urban, Nassrin Koch-Khoury, Andreas Fellgiebel · 2009 · Journal of Neurology
32. Novel therapies for combating chronic neuropathological sequelae of TBI
    Miloš D. Ikonomović, Eric E. Abrahamson, Shaun W. Carlson, Steven H. Graham, C. Edward Dixon · 2018 · Neuropharmacology
33. Spatiotemporal relationship between subthreshold amyloid accumulation and aerobic glycolysis in the human brain
    Manu S. Goyal, Brian Andrew Gordon, Lars E. Couture, Shaney E. Flores, Chengjie Xiong, John C. Morris, Marcus E. Raichle, Tammie L.S. Benzinger, Andrei G. Vlassenko · 2020 · Neurobiology of Aging
34. Local and distributed PiB accumulation associated with development of preclinical Alzheimer's disease
    Matthew R. Brier, John Edward McCarthy, Tammie L.S. Benzinger, Ari Stern, Yi Su, Karl A. Friedrichsen, John C. Morris, Beau M. Ances, Andrei G. Vlassenko · 2015 · Neurobiology of Aging
35. Clinical field-strength MRI of amyloid plaques induced by low-level cholesterol feeding in rabbits
    John Andrew Ronald, Yuanxin Chen, Lisa M. Bernas, Hagen H. Kitzler, Kem A. Rogers, Robert Alexander Hegele, Brian K. Rutt · 2009 · Brain
36. In vivo characterization of a bigenic fluorescent mouse model of Alzheimer’s disease with neurodegeneration
    Crowe, Sarah E., Ellis‐Davies, Graham C.R. · 2013 · Journal of Comparative Neurology
37. Understanding Biomarkers of Neurodegeneration: Novel approaches to detecting tau pathology
    Casey N. Cook, Melissa Erin Murray, Leonard Petrucelli · 2015 · Nature Medicine
38. A contrast in safety, pharmacokinetics and pharmacodynamics across age groups after a single 50 mg oral dose of the γ‐secretase inhibitor avagacestat
    Gary Tong, Jun‐Sheng Wang, Oleksandr Sverdlov, Shu‐Pang Huang, Randy Slemmon, Robert S. Croop, Lorna Castaneda, Huidong Gu, Oi T. Wong, Hewei Li et al. · 2012 · British Journal of Clinical Pharmacology
39. Mild Cognitive Impairment
    2006 · Wiley eBooks
40. Bivariate correlation coefficients in family‐type clustered studies
    Luo, Jingqin, D'Angelo, Gina, Gao, Feng, Ding, Jimin, Xiong, Chengjie · 2015 · Biometrical Journal
41. Vesicular Glutamate Transporter Changes in the Cortical Default Mode Network During the Clinical and Pathological Progression of Alzheimer’s Disease
    Zhiping Mi, Eric E. Abrahamson, Angela Y. Ryu, Michael H. Malek‐Ahmadi, Julia Kofler, Kenneth N. Fish, Robert A. Sweet, Victor L. Villemagne, Julie A. Schneider, Elliott Jay Mufson et al. · 2023 · Journal of Alzheimer s Disease
42. Biomarcadores en la enfermedad de Alzheimer
    Guillermo García Ribas, José Luis López-Sendón, Juan García Caldentey · 2014 · Revista de Neurología
43. In vivo characterization of a bigenic fluorescent mouse model of Alzheimer's disease with neurodegeneration
    Sarah E. Crowe, Graham C. R. Ellis‐Davies · 2013 · The Journal of Comparative Neurology
44. Combining Multiple Markers to Improve the Longitudinal Rate of Progression: Application to Clinical Trials on the Early Stage of Alzheimer's Disease
    Chengjie Xiong, Gerald van Belle, Kewei Chen, Lili Tian, Jingqin Rosy Luo, Feng Gao, Yan Yan, Ling Chen, John C. Morris, Paul K. Crane · 2013 · Statistics in Biopharmaceutical Research
45. Amyloid Imaging with PET in Alzheimer’s Disease, Mild Cognitive Impairment, and Clinically Unimpaired Subjects
    William Edward Klunk, Chester A. Mathis, Julie C. Price, Steven Trent DeKosky, Brian J. Lopresti, Nicholas D. Tsopelas, Judith A. Saxton, Robert D. Nebes · 2009 · Springer eBooks
46. The Role of Aβ-Peptide on Spatial Memory, EEG, Auditory Evoked Potentials And Nicotinic Cholinergic Receptors in A/P Transgenic Mice
    Jun Wang · 2003
47. Soluble amyloid-beta isoforms predict downstream Alzheimer’s disease pathology
    Guilherme Povala, Bruna Bellaver, Marco Antônio De Bastiani, Wagner Scheeren Brum, Pâmela C.L. Ferreira, Andrei Bieger, Tharick Ali Pascoal, Andréa Lessa Benedet, Diogo Onofre Souza, Ricardo Araújo et al. · 2021 · Cell & Bioscience
48. Appropriate use criteria for amyloid PET imaging cannot replace guidelines: On behalf of the European Association of Nuclear Medicine
    Jan Booij, Javier Arbizu, Jacques Darcourt, Swen Hesse, Flavio Mariano Nobili, Pierre Payoux, Sabina Pappatà, Klaus Tatsch, Zuzana Walker, Marco Pagani · 2013 · European Journal of Nuclear Medicine and Molecular Imaging
49. Biomarker-Based Prediction of Progression to Dementia: F-18 FDG-PET in Amnestic MCI
    Madhavi Tripathi, Manjari Tripathi, GirishKumar Parida, Rajeev Kumar, Sadanand N. Dwivedi, Ashima Nehra, Chandrasekhar Bal · 2019 · Neurology India
50. A Chronic Increase in Blood-Brain Barrier Permeability Facilitates Intraneuronal Deposition of Exogenous Bloodborne Amyloid-Beta1–42 Peptide in the Brain and Leads to Alzheimer’s Disease-Relevant Cognitive Changes in a Mouse Model
    Nimish K. Acharya, Henya C. Grossman, Peter M. Clifford, Eli C. Levin, Kenneth Light, Ha-Na Choi, Randel L. Swanson, Mary C. Kosciuk, Venkat Venkataraman, David J. Libon et al. · 2024 · Journal of Alzheimer s Disease
51. Identifying brain functional alterations in postmenopausal women with cognitive impairment
    Jingjing Huang, Feng Bai, Xiaoqing Yang, Chen Chen, Xueping Bao, Yuquan Zhang · 2015 · Maturitas
52. Proteomic analysis of plasma from a Tau transgenic mouse
    Yoon‐Ha Kim, E. C. Lee, Seung‐Ah Park, Nam‐Hee Kim, Chan‐Wha Kim · 2012 · International Journal of Developmental Neuroscience
53. Alzheimer’s Disease Pathology in Middle Aged and Older People with HIV: Comparisons with Non-HIV Controls on a Healthy Aging and Alzheimer’s Disease Trajectory and Relationships with Cognitive Function
    Erin E. Sundermann, Laura M. Campbell, Olivia Villers, Mark William Bondi, Ben D. Gouaux, David P. Salmon, Douglas R Galasko, Virawudh Soontornniyomkij, Ronald J. Ellis, David J. Moore · 2023 · Viruses
54. Biomarkers in Alzheimer’s disease
    Vida Demarin, Iris Zavoreo, Vanja Bašić Kes, Ana-Maria Šimundić · 2011 · Clinical Chemistry and Laboratory Medicine (CCLM)
55. Molecular basis of memory loss in the Tg2576 mouse model of Alzheimer's disease
    Karen H. Ashe · 2006 · Journal of Alzheimer s Disease
56. Clinical Dementia Rating Performed Several Years prior to Death Predicts Regional Alzheimer’s Neuropathology
    Michal Schnaider Beeri, Jeremy M. Silverman, James Schmeidler, Michael Wysocki, Hillel T. Grossman, Dushyant P. Purohit, Daniel P. Perl, Vahram H. Haroutunian · 2008 · Dementia and Geriatric Cognitive Disorders
57. La Lunga Attesa : Towards a Molecular Approach to Neuroimaging and Therapeutics in Alzheimer's Disease
    Victor L. Villemagne, S. Ng, Roberto Cappai, Kevin Jeffrey Barnham, Michelle T. Fodero‐Tavoletti, Chris C. Rowe, Colin Louis Masters · 2006 · The Neuroradiology Journal
58. Event-related potentials for the diagnosis of mild cognitive impairment and Alzheimer's disease
    Vasilios Κ. Kimiskidis, Vasileios T. Papaliagkas · 2011 · Expert Opinion on Medical Diagnostics
59. Voluntary Wheel Running Did Not Alter Gene Expression in 5xfad Mice, but in Wild-Type Animals Exclusively after One-Day of Physical Activity
    Anna Wierczeiko, Lena Gammel, Konstantin Radyushkin, Vu Thu Thuy Nguyen, Hristo Todorov, Susanne Gerber, Kristina Endres · 2021 · Cells
60. Platelet Membrane β-Secretase Activity in Mild Cognitive Impairment and Conversion to Dementia: a Longitudinal Study
    Bernadette McGuinness, Marc Fuchs, Suzanne Barrett, A. Peter Passmore, Janet A. Johnston · 2015 · Journal of Alzheimer s Disease
61. Risk Stratification Using Cerebrospinal Fluid Biomarkers in Patients with Mild Cognitive Impairment: An Exploratory Analysis
    Tzeyu L. Michaud, Alzheimer’s Disease Neuroimaging Initiative, Robert L Kane, John Riley McCarten, Joseph E. Gaugler, John A. Nyman, Karen M. Kuntz · 2015 · Journal of Alzheimer s Disease
62. Synthesis and evaluation of 2-pyrrolopyridinylquinoline derivatives as selective tau PET tracers for the diagnosis of Alzheimer's disease.
    P. Lerdsirisuk, R. Harada, Y. Hayakawa, Yuki Shimizu, Y. Ishikawa, R. Iwata, Yukitsuka Kudo, N. Okamura, S. Furumoto · 2020 · Nuclear Medicine and Biology
63. The Application of Deep Learning for Classification of Alzheimer's Disease Stages by Magnetic Resonance Imaging Data.
    Muhammad Irfan Khattak, Seyed A. Shahrestani, Mahmoud Elkhodr · 2023 · International Journal of Interactive Multimedia and Artificial Intelligence
64. Linear combinations of multiple outcome measures to improve the power of efficacy analysis – application to clinical trials on early-stage Alzheimer's disease
    Chengjie Xiong, Jingqin Rosy Luo, John C. Morris, Randall John Bateman · 2017 · Biostatistics & Epidemiology
65. Chronic agomelatine treatment alleviates icvAβ-induced anxiety and depressive-like behavior through affecting Aβ metabolism in the hippocampus in a rat model of Alzheimer's disease
    Kalina Ilieva, Milena Atanasova, Dimitrinka Atanasova, Lidia Kortenska, Jana Dimitrova Tchekalarova · 2021 · Physiology & Behavior
66. Are self-management abilities beneficial for frail older people’s cognitive functioning?
    Jane Murray Cramm, Anna P. Nieboer · 2022 · BMC Geriatrics
67. Exploring the Impact of Age of Onset of Mild Cognitive Impairment on the Profile of Cognitive and Psychiatric Symptoms
    Kleio Moustaka, Chrysanthi Nega, Ion Beratis · 2023 · Geriatrics
68. The Effects of Gene Mutations on Default Mode Network in Familial Alzheimer’s Disease
    Xiaozhen Li, Eric Westman, Steinunn Þórðardóttir, Anne Kinhult Ståhlbom, Ove Almkvist, Kaj Blennow, Lars‐Olof Wahlund, Caroline Graff · 2016 · Journal of Alzheimer s Disease
69. Differences in Semantic Memory Encoding Strategies in Young, Healthy Old and MCI Patients
    Gil Suzin, Ramit Ravona‐Springer, Elissa L. Ash, Eddy J. Davelaar, Marius Usher · 2019 · Frontiers in Aging Neuroscience
70. Cortical Thickness Differences Are Associated With Chemical Synaptic Transmission Upregulated Genes in Degeneration of Mild Cognitive Impairment
    Suping Cai, Kexin Huang, Fan Yang, Xuwen Wang, Sijia Wu, Yübo Wang, Liyu Huang · 2021 · Frontiers in Aging Neuroscience
71. The Micron Stroke Hypothesis of Alzheimer’s Disease and Dementia
    Allen J. Orehek · 2012 · Medical Hypotheses
72. Aβ conformational change is central to Alzheimer’s disease
    David M. Holtzman · 2002 · Neurobiology of Aging
73. Interventions for Mild Cognitive Impairment and Alzheimer Disease: New Strategies, New Hope
    Pudugramam Murali Doraiswamy · 2003 · American Journal of Geriatric Psychiatry
74. Cognitive functioning in the preclinical stages of Alzheimer´s disease and vascular dementia
    Sari Jones · 2005 · Figshare
75. Weight loss as a predictor of dementia and Alzheimer’s disease?
    Fati Nourhashémi, Bruno J. Vellas · 2008 · Expert Review of Neurotherapeutics
76. Resilience to AD pathology in Top Cognitive Performers
    Elena Nicole Dominguez, María M. Corrada, Claudia H. Kawas, Craig E.L. Stark · 2024 · Frontiers in Aging Neuroscience
77. Cannabis Use and Cannabidiol Modulate HIV-Induced Alterations in TREM2 Expression: Implications for Age-Related Neuropathogenesis
    Bryant Avalos, Jacqueline Renee Kulbe, Mary K. Ford, Anna Elizabeth Laird, Kyle Walter, Michael Mante, Jazmin B. Florio, Ali Boustani, Antoine Chaillon, Johannes C. M. Schlachetzki et al. · 2024 · Viruses
78. Combination therapy prevents amyloid-dependent and -independent structural changes
    Gauri H. Malthankar‐Phatak, Shane G. Poplawski, Nikhil Toraskar, Robert G. Siman · 2011 · Neurobiology of Aging
79. Una nueva aproximación en el diagnóstico de la enfermedad de Alzheimer con biomarcadores: descripción del AD-CSF-Index
    José Luís Molinuevo, Juan Domingo Gispert, Jesús Pujol, Santiago Rojas, Albert Lladó Plarrumaní, Mircea Balasa, Anna Antonell, Raquel Sánchez‐Valle, Lorena Rami González · 2012 · Revista de Neurología
80. Movement as a Positive Modulator of Aging
    Marie Bičı́ková, Ludmila Máčová, Dobroslava Jandová, Zdeněk Třískala, Martin Hill · 2021 · International Journal of Molecular Sciences
81. Five-Year Dynamic Prediction of Dementia Using Repeated Measures of Cognitive Tests and a Dependency Scale
    Céline Ben Hassen, Catherine Helmer, Claudine Berr, Hélène Jacqmin‐Gadda · 2021 · American Journal of Epidemiology
82. Age-related mild cognitive deficit: a ready-to-use concept?
    Christian Gilles · 2003 · Dialogues in Clinical Neuroscience
83. Interfering effect and mechanism of neuregulin on experimental dementia model in rats
    Yan Chen, Meizeng Zhang, Qin Li, Yunliang Guo, Wei Ding, Lihua Wang, Zhen Zhou, Xiping Chen · 2011 · Behavioural Brain Research
84. Neurobiology of Alzheimer’s Disease
    Philip C. Wong, Alena V. Savonenko, Tong Li, Donald L. Price · 2012 · Elsevier eBooks
85. β-Amyloid Treatment Sensitizes Mice to Amphetamine-Induced Locomotion but Reduces Response to Caffeine
    Oscar Phelippe Permigotti Dall'Igna, Anselmo Hoffmann, Adriana L. da Silva, Diogo Onofre Souza, Diogo Rizzato Lara · 2004 · Neurodegenerative Diseases
86. The dynamics of cognitive decline toward Alzheimer's disease progression: Results from ADSP‐PHC's harmonized cognitive composites
    Kaidi Kang, Panpan Zhang, Logan C. Dumitrescu, Shubhabrata Mukherjee, Michael L. Lee, Seo‐Eun Choi, Emily H. Trittschuh, Jesse B Mez, Andrew J. Saykin, Katherine A. Gifford et al. · 2025 · Alzheimer s & Dementia
87. Abnormal motor cortical plasticity as a useful neurophysiological biomarker for Alzheimer’s disease pathology
    Takenobu Murakami, Mitsunari Abe, Amanda Tiksnadi, Ayaka Nemoto, Miyako Futamura, Ryo Yamakuni, Hitoshi Kubo, Naoto Kobayashi, Hiroshi Ito, Ritsuko Hanajima et al. · 2024 · Clinical Neurophysiology
88. A multilayer network analysis of Alzheimer's disease pathogenesis: Roles for p‐tau, synaptic peptides, and physical activity
    Andrea A. Jones, Alfredo Ramos‐Miguel, Kristina M. Gicas, Vladislav Petyuk, Sue E. Leurgans, Philip L. De Jager, Julie A. Schneider, David Bennett, William G. Honer, Kaitlin Blackstone Casaletto · 2024 · Alzheimer s & Dementia
89. Association of Alzheimer's Disease With APOE and IL-1α Gene Polymorphisms
    Saliha Handan Yıldız, Müjgan Özdemir Erdoğan, Sevilhan Artan, Mustafa Solak, Mehmet Yaman, Belgin Demet Ozbabalik, Evrim Suna Arıkan Söylemez · 2012 · American Journal of Alzheimer s Disease & Other Dementias®
90. Cognitive Improvement in Healthy Older Adults Can Parallel That of Younger Adults Following Lifestyle Modification: Support for Cognitive Reserve During Aging
    Thomas B. Shea, Ruth Remington · 2018 · Journal of Alzheimer s Disease Reports
91. Vascular cognitive impairment: prodrome to VaD?
    Mayda, Adriane, DeCarli, Charles · 2009 · Vascular Cognitive Impairment in Clinical Practice
92. Cross‐sectional and longitudinal comparisons of biomarkers and cognition among asymptomatic middle‐aged individuals with a parental history of either autosomal dominant or late‐onset Alzheimer's disease
    Chengjie Xiong, Lena M. McCue, Virginia Buckles, Elizabeth Grant, Folasade Agboola, Dean W. Coble, Randall John Bateman, Anne M. Fagan, Tammie L.S. Benzinger, Jason J. Hassenstab et al. · 2023 · Alzheimer s & Dementia
93. Deterioro cognitivo ligero, ¿una entidad necesaria?
    Manuel Martín Carrasco, Antonio Bulbena · 2007 · Redalyc (Universidad Autónoma del Estado de México)
94. Effects of Misdiagnosis in Input Data on the Identification of Differential Expression Genes in Incipient Alzheimer Patients
    Sandeep J. Joseph, Kelly R. Robbins, Wensheng Zhang, Romdhane Rekaya A · 2008 · In Silico Biology
95. Molecular genetics of early-onset Alzheimer's disease and frontotemporal lobar degeneration
    Johanna Krüger · 2010
96. Visuoperceptual repetition priming and progression of parkinsonian signs in aging
    Debra A. Fleischman, Aron S. Buchman, Julia L. Bienias, David Alan Bennett · 2007 · Neurobiology of Aging
97. Recent Trends in Nano-Particulate Carriers for the Diagnosis and Treatment of Alzheimer’s Disease
    Awesh Kumar Yadav, Farhan Mazahir · 2022 · CNS & Neurological Disorders - Drug Targets
98. Opposite Roles of Co-enzyme Q10 and Formaldehyde in Neurodegenerative Diseases
    Jinan Xu, Xingjiang Jin, Zuting Ye, Dandan Wang, Hang Zhao, Zhiqian Tong · 2022 · American Journal of Alzheimer s Disease & Other Dementias®
99. Historical perspectives on the discovery and development of drugs to treat neurological disorders
    Michael J. Williams, JOSEPH T. COYLE · 2012 · Cambridge University Press eBooks
100. Amnestic mild cognitive impairment
     Christopher Butler, Samrah Ahmed · 2016 · Cambridge University Press eBooks